Graphene oxide as novel vaccine adjuvant.

To improve antigen immunogenicity and promote long-lasting immunity, vaccine formulations have been appropriately supplemented with adjuvants. Graphene has been found to enhance the presentation of antigens to CD8+ T cells, as well as stimulating innate immune responses and inflammatory factors. Its properties, such as large surface area, water stability, and high aspect ratio, make it a suitable candidate for delivering biological substances. Graphene-based nanomaterials have recently attracted significant attention as a new type of vaccine adjuvants due to their potential role in the activation of immune responses. Due to the limited functionality of some approved human adjuvants for use, the development of new all-purpose adjuvants is urgently required. Research on the immunological and biomedical use of graphene oxide (GO) indicates that these nanocarriers possess excellent physicochemical properties, acceptable biocompatibility, and a high capacity for drug loading. Graphene-based nanocarriers also could improve the function of some immune cells such as dendritic cells and macrophages through specific signaling pathways. However, GO injection can lead to significant oxidative stress and inflammation. Various surface functionalization protocols have been employed to reduce possible adverse effects of GO, such as aggregation of GO in biological liquids and induce cell death. Furthermore, these modifications enhance the properties of functionalized-GO's qualities, making it an excellent carrier and adjuvant. Shedding light on different physicochemical and structural properties of GO and its derivatives has led to their application in various therapeutic and drug delivery fields. In this review, we have endeavored to elaborate on different aspects of GO.

Application of FeOOH Nano-Ellipsoids as a Novel Nano-Based Iron Supplement: an In Vivo Study.

The possibility of employing FeOOH nano-ellipsoids as a novel shape nano-based iron supplement was investigated. Ferrous sulfate and nano-ellipsoids were daily administered by gavage at low and high dosages. After 1 month of treatment, the hematologic parameters along with serum and organs' iron contents were measured. Liver enzymes, total serum bilirubin, and LDH level were assayed to evaluate any possible toxicity. More investigation was also performed by organ index calculation and also pathologic studies. It was found that nano-ellipsoids are an effective iron supplement to improve iron-related blood parameters. Interestingly, low-dose nano-ellipsoids were even more effective than high-dose ferrous sulfate. Nano-ellipsoids had no considerable impact on the liver enzymes and serum bilirubin. Meanwhile, high-dose ferrous sulfate significantly increases liver enzyme activity. The increased serum LDH was also the only concern in the groups that were treated with high-dose ferrous sulfate and nano-ellipsoids. Pathologic evaluations revealed some signs of liver inflammation after supplementation with high dose nano-ellipsoids and also ferrous sulfate. Overall, these data indicate FeOOH nano-ellipsoids as a novel shape iron supplement to be employed at low dosage but with greater beneficial effects than high-dose ferrous sulfate.

Size Tuned Synthesis of FeOOH Nanorods toward Self-Assembled Nanoarchitectonics.

Various studies were performed to fabricate self-assembling nanoobjects out of noble metals, but a few efforts were made for engineering iron-based nanorods toward sell-assembling blocks. In this regard ß-FeOOH nanorods were fabricated in various sizes to achieve iron-based rod nanoblocks with self-assembling potential. Hydrolysis of ferric ions in various concentrations was successfully developed as a novel approach to control the growth of ß-FeOOH crystals and tuning the length of rods in the nano range, below 100 nm. It was found that the concentration of ferric ion has no effect on the widths of nanorods, but the length was affected. By increasing the concentration of ferric ions, an increase in the length of nanorods and an increase of aspect ratio occurred. All sizes of the resulting FeOOH nanorods exhibited mesoporous feature, but interestingly the hysteresis loops were different due to different pore patterns. In fact, pores on the larger particles were more uniform in size and shape. Nanorods of small length did not make suitable interactions toward ordered phase formation, but rods with the mean length of about 90 nm or longer, at a certain concentration, were able to form nematic phases. The large (∼+40 mV) zeta-potential of nanorods prevents formation of dense arrays, and just bundle-like structures were observed. These findings highlight the importance of size, surface charge, and concentration of nanoobjects in the formation of 3D structures. The developed technique in the fabrication of ß-FeOOH nanorods provides pure structures that are free from any size-controlling agent. These pure structures are suitable for further functionalization or coating. Self-assembling nanoobjects is a developing field in nanotechnology, and therefore studies can help our understanding over the assembling process.